Improve Workflow with Home INR Monitoring
Focus on patients with greater clinical needs, while improving your practice efficiencies. If patients report directly to Alere, either live or into our secure database management system, we can:
- Send you all patient test results on the schedule you choose
- Alert you only when a patient is out-of-range
- Provide access to patient results electronically
Using Management by Exception, in-range patients follow set protocols and do not regulate a contact after every test allowing you to concentrate on those patients at higher risk or needing intervention.
Establish an Outpatient Protocol
The results of the “Warfarin management by exception, use of an outpatient protocol with patient self-testers” study found significant clinical benefits for the patient and operational benefits to the provider.1 Use of a physician-issued outpatient protocol for patient self-testing is referenced in Medicare’s National Coverage Decision for patient self-testing and was used in 10 studies evaluated by Medicare prior to issuing reimbursement for self-testing.2
Outpatient Protocol Results
Patient safety was a primary endpoint of the Management by Exception study. Results included a dramatic 37% reduction in the incidence of critical value test results (less than 1.5 or greater than 5.0 that result in significant increased risk of stroke or major bleed) in the study phase that used the outpatient protocol. 2,3,4
Our program offers support tools for clinics establishing protocols. Ask a Representative how!
Operational Benefits for use of the Outpatient Protocol
Cost avoidance, improved warfarin control, and improved patient safety resulted when an outpatient protocol provided weekly patient self-testers easy to follow instructions for out-of-range results (1.8 – 3.9). Increased practice efficiency resulted in less telephonic follow-up management time for weekly self-testers.
- Heneghan C, et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. 2006; 367:404-11.
- CMS National Decision Memo for Prothrombin Time (INR) Monitor for Home Anticoagulation Management (CAG-00087R), 03/19/2008. http://www.cms.hhs.gov/mcd/viewtrackingsheet.asp?id=209
- Burgwinkle, P. 2013, Warfarin management by exception, use of an outpatient protocol with patient self-testers. [pending publishing].
- Hylek, E. New England Journal of Medicine. 1996. Vol.335, No.8, p.540-6.
Home INR Monitoring can have a positive economic impact on your practice.
Many factors can affect the economic impact that in-office point-of-care testing and patient self-testing may have on your practice:
- Schedule of regular in-office visits to augment home monitoring
- Prescribed frequency of testing at home
- Process of managing out-of-range results
- Length of time to manage patients during intervention
- Management protocols for patient self-testers
Home INR Monitoring complements routine clinician care. There are no costs to the practice when prescribing Home INR Monitoring to your patients. The program is designed to augment, not replace regularly scheduled office visits.
Reimbursable for physicians1
Medicare and many private insurers reimburse physicians CPT code G0250 for the review and interpretation of test results performed by patients at home. Depending upon the training method selected, there is also reimbursement (G0248) available for initial training on the INR monitor.
For additional reimbursement support, look up CPT® & ICD-10codes, coverage policies, and state by state Medicare reimbursement information go to www.codemap.com/alere. Or contact the CodeMap® Hotline at 847.381.5465, ext 5.
Alere™ Home INR Monitoring offers greater visibility and tighter control.
The STABLE Study demonstrates weekly patient self-testing provides sustained high quality, cost-effective warfarin control.
Contact Alere at 1.866.408.1205 for more information.